Brown Advisory
AVNS

Brown Advisory’s Avanos Medical AVNS Stock Holding History

Brown Advisory’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,231,198
Closed -$31.3M – 1456
2026
Q1 		$31.3M Buy
2,231,198
+295,396
+15% +$3.98M 0.05% 253
2025
Q4 		$21.7M Sell
1,935,802
-290,954
-13% -$3.33M 0.03% 316
2025
Q3 		$25.7M Buy
2,226,756
+417,921
+23% +$4.89M 0.03% 288
2025
Q2 		$22.1M Sell
1,808,835
-122,328
-6% -$1.54M 0.03% 301
2025
Q1 		$27.7M Buy
1,931,163
+26,069
+1% +$407K 0.04% 261
2024
Q4 		$30.3M Buy
1,905,094
+204,218
+12% +$4.04M 0.04% 281
2024
Q3 		$40.9M Buy
1,700,876
+30,093
+2% +$688K 0.05% 247
2024
Q2 		$33.3M Buy
1,670,783
+274,920
+20% +$5.35M 0.04% 259
2024
Q1 		$27.8M Buy
+1,395,863
New +$27M 0.04% 291
2021
Q2 		– Sell
-5,148
Closed -$225K – 1077
2021
Q1 		$225K Hold
5,148
– – ﹤0.01% 1004
2020
Q4 		$236K Buy
+5,148
New +$214K ﹤0.01% 930
2019
Q4 		– Sell
-6,245
Closed -$234K – 1042
2019
Q3 		$234K Sell
6,245
-237
-4% -$9.04K ﹤0.01% 911
2019
Q2 		$283K Sell
6,482
-106
-2% -$4.53K ﹤0.01% 883
2019
Q1 		$282K Sell
6,588
-273
-4% -$12.2K ﹤0.01% 1138
2018
Q4 		$308K Buy
6,861
+22
+0.3% +$1.15K ﹤0.01% 1065
2018
Q3 		$469K Sell
6,839
-100
-1% -$6.43K ﹤0.01% 1009
2018
Q2 		$397K Buy
6,939
+131
+2% +$6.92K ﹤0.01% 1032
2018
Q1 		$314K Buy
6,808
+69
+1% +$3.28K ﹤0.01% 958
2017
Q4 		$311K Sell
6,739
-1,049
-13% -$48.2K ﹤0.01% 1033
2017
Q3 		$351K Sell
7,788
-276
-3% -$11.8K ﹤0.01% 963
2017
Q2 		$318K Buy
8,064
+375
+5% +$14.2K ﹤0.01% 999
2017
Q1 		$293K Sell
7,689
-27
-0.3% -$1.05K ﹤0.01% 987
2016
Q4 		$286K Sell
7,716
-246
-3% -$8.79K ﹤0.01% 943
2016
Q3 		$275K Buy
7,962
+64
+0.8% +$2.24K ﹤0.01% 903
2016
Q2 		$256K Sell
7,898
-70
-0.9% -$2.14K ﹤0.01% 898
2016
Q1 		$229K Buy
+7,968
New +$212K ﹤0.01% 890

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Brown Advisory's AVNS Position: Q2 2026 in Review

Brown Advisory sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 2,231,198 shares — an estimated $31.3M sold.

Brown Advisory first reported a position in AVNS in Q1 2016 and held it in 26 quarters. The position peaked at $40.9M in Q3 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Brown Advisory reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • Brown Advisory sold 2,231,198 Avanos Medical shares in Q2 2026, an estimated $31.3M.
  • Brown Advisory first reported a position in Avanos Medical in Q1 2016 and held it in 26 quarters.
  • Brown Advisory's Avanos Medical position peaked at $40.9M in Q3 2024.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.